Home・Aandelen Lijst・Travere Therapeutics Inc

Travere Therapeutics Inc

Gesloten

62.1 3.19

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

59.87

Max

61.92

Belangrijke statistieken
By Trading Economics
Inkomsten	1.3M -35M
Verkoop	42M 170M
EPS	-0.37
Winstmarge	-20.814
Werknemers	497
EBITDA	-24M -33M

Aanbevelingen
By TipRanks
Aanbevelingen	Strong Buy
12 Maanden Prognose	+20.02% upside

Dividenden
By Acuity
Volgende Winsten	29 okt 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	627M 5.7B
Vorige openingsprijs	58.91
Vorige sluitingsprijs	62.1

Travere Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

11 aug 2026, 23:56 UTC

Coherent Corp shares are higher in after-market trading, continuing a strong upward trend since Tuesday's close amid broader market volatility and fluctuating oil prices.

11 aug 2026, 23:56 UTC

Paychex Inc. shares are higher in after-market trading, maintaining a position above its 20-day moving average amid recent volatility in Brent crude oil prices.

11 aug 2026, 23:56 UTC

Arcos Dorados Holdings shares are higher in after-market trading, despite five consecutive lower sessions. Market volatility is influenced by rising Brent crude oil prices.

11 aug 2026, 23:56 UTC

Citizens Financial Group Inc shares are higher in after-hours trading, remaining above their 20-day moving average and near the upper end of their one-month range.

11 aug 2026, 23:56 UTC

News

GrowGeneration reports second-quarter net sales of $43.2 million, a 5.5% increase. Shares are higher in after-market trading following the earnings announcement.

11 aug 2026, 23:56 UTC

Assurant Inc. shares rose after-market, recovering from an early dip amid broader market volatility linked to Brent crude oil fluctuations and investor caution ahead of CPI data.

11 aug 2026, 23:56 UTC

News

Digital Realty Trust announced a quarterly dividend of $1.22 per share. Shares are trading higher in after-market hours following the announcement.

11 aug 2026, 23:56 UTC

Macy's Inc. shares are higher in after-market hours, driven by notable strength in the Broadline Retail sub-sector, despite no specific company news identified.

11 aug 2026, 23:56 UTC

Monro Inc shares are trading higher in after-market hours amid broader market volatility and rising Brent crude oil prices above $90 per barrel.

11 aug 2026, 23:56 UTC

Social Media

Twilio Inc shares are higher in after-market hours, supported by social media discussions on a "massive stage 1 base breakout" and increased full-year guidance.

11 aug 2026, 23:56 UTC

Kaiser Aluminum Corp shares are higher in after-market trading. The stock remains above its 20-day moving average amid broader market volatility.

11 aug 2026, 23:56 UTC

Alibaba Group Holding Ltd shares are higher in after-market trading, reflecting routine performance within a narrow range above the 20-day moving average.

11 aug 2026, 23:56 UTC

CH Robinson Worldwide shares are trading higher in after-market hours, reflecting some resilience amid broader market volatility and fluctuating Brent crude oil prices.

11 aug 2026, 23:56 UTC

Fluence Energy Inc shares are higher in after-market hours, trading within a narrow range. No specific news was identified to explain the movement.

11 aug 2026, 23:56 UTC

Chemours Co shares are higher in after-market trading, reflecting notable activity since Tuesday's close. The stock remains below its 20-day moving average.

11 aug 2026, 23:56 UTC

Genco Shipping & Trading Ltd shares are higher in after-market trading, rising from session lows despite being below its 20-day moving average and near a one-month low.

11 aug 2026, 23:56 UTC

Broadridge Financial Solutions Inc shares are higher in after-market trading, recovering from a session dip and remaining above the 20-day moving average.

11 aug 2026, 23:56 UTC

News

UBS maintains Buy rating on Rapid7 and raises price target to $12. Shares are trading higher in after-market hours, reflecting positive investor sentiment.

11 aug 2026, 23:56 UTC

Kraft Heinz Co shares are trading slightly higher in after-market hours. No specific news was identified to explain this movement.

11 aug 2026, 23:56 UTC

PennyMac Mortgage Investment Trust shares are higher in after-market trading, reflecting a slight uptick amid broader market volatility. No specific news was identified.

11 aug 2026, 23:56 UTC

Correlated Moves

American Water Works Company reported no specific news after-market hours. The stock was roughly flat, reflecting broader market sentiment and stability.

11 aug 2026, 23:56 UTC

Atmos Energy Corp shares are trading higher in after-market hours. This movement occurs amid broader market volatility and fluctuating Brent crude oil prices.

11 aug 2026, 23:56 UTC

Axon Enterprise Inc. shares are lower in after-market trading, despite a recent trend of three consecutive higher daily closes.

11 aug 2026, 23:52 UTC

ETF Constituents

Correlated Moves

Macro News

iShares MSCI South Korea ETF rises in after-market trading, supported by technology stock gains and broader equity market movements. It remains above its 20-day moving average.

11 aug 2026, 23:52 UTC

Monster Beverage Corp. shares rose during after-market hours, recovering from a slight pullback. Market focus remains on upcoming economic data, including the CPI report.

11 aug 2026, 23:52 UTC

Social Media

Entravision Communications Corp shares are rising in after-market trading amid positive investor sentiment and discussions of potential favorable price movements.

11 aug 2026, 23:52 UTC

Correlated Moves

Booking Holdings Inc shares are lower in after-market hours amid broader market declines. Investors await the upcoming consumer price index report for further guidance.

11 aug 2026, 23:51 UTC

Xpeng Inc. shares were roughly flat in after-market trading. Market attention remains on the upcoming consumer price index report amid recent job loss data.

11 aug 2026, 23:51 UTC

Correlated Moves

Cohu Inc. shares are lower in after-market trading, influenced by a slight decline in the Nasdaq 100 Index and overall market sentiment.

11 aug 2026, 23:51 UTC

Eton Pharmaceuticals Inc shares are lower in after-market trading amid unusual volatility. No specific news was identified to explain the decline.

Peer Vergelijking

Prijswijziging

Travere Therapeutics Inc Prognose

Koersdoel

By TipRanks

20.02% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 73.08 USD 20.02%

Hoogste 90 USD

Laagste 49 USD

Gebaseerd op 12 Wall Street-analisten die 12-maands prijsdoelen bieden voor Travere Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

12 ratings

Buy

Hold

Sell

Gebaseerd op 12 analisten die aandelenratings hebben gegeven aan Travere Therapeutics Inc - Dist in de afgelopen 3 maanden.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Travere Therapeutics Inc

Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases. Its products include FILSPARI (sparsentan), a once-daily, oral medication designed to target two critical pathways in the disease progression of IgA Nephropathy (endothelin 1 and angiotensin-II); and Thiola and Thiola EC (tiopronin tablets) for the treatment of cystinuria, a rare genetic cystine transport disorder that causes high cystine levels in the urine and the formation of recurring kidney stones. The company's clinical-stage programs consist of Sparsentan, a novel investigational product candidate, which has been granted Orphan Drug Designation for the treatment of focal segmental glomerulosclerosis in the U.S. and Europe; and Pegtibatinase (TVT-058), a novel investigational human enzyme replacement candidate being evaluated for the treatment of classical homocystinuria. It has a cooperative research and development agreement with National Institutes of Health's National Center for Advancing Translational Sciences and Alagille Syndrome Alliance for the identification of potential small molecule therapeutics for Alagille syndrome. The company was formerly known as Retrophin, Inc. and changed its name to Travere Therapeutics, Inc. in November 2020. Travere Therapeutics, Inc. was incorporated in 2008 and is headquartered in San Diego, California.